Joint
Meeting of the Nonprescription Drugs Advisory Committee
and
the
Endocrinologic
and Metabolic Drugs Advisory Committee
January
23, 2006
Table of Contents
Section:
1.
Draft Issues for Discussion
3.
Clinical Review of Safety and
Efficacy; Division of Metabolism and Endocrinology Products
4.
Memo from the Division of Pediatric
Drug Development
5.
Statistical Review;
Division of Biometrics II
6.
Amended
Statistical Review, Division of Biometrics II
7.
Label Comprehension Review;
Division of NonPrescription Clinical Evaluation
8. Clinical Review of the Actual Use Study; Division of NonPrescription Clinical Evaluation